Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's Syndrome
Clinical trial NCT02495129 · WITHDRAWN
Trial details
- NCT number
- NCT02495129
- Sponsor
- Novartis Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2017-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.